Gf Fund Management Co., Ltd. - CSI Hong Kong Brand Name Drug Index ETF (SHA:513120)
1.361
+0.004 (0.29%)
At close: Sep 23, 2026
SHA:513120 Holdings Information
SHA:513120 is an equity ETF with a total of 44 individual holdings. The top holdings are Innovent Biologics stock at 10.15%, BeOne Medicines AG at 9.76%, WuXi AppTec at 8.60%, WuXi Biologics at 8.51%, and Akeso at 7.34%.
Total Holdings
44
Top 10 Percentage
70.17%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
18.67
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 1801 | Innovent Biologics, Inc. | 10.15% |
| 2 | HKG: 6160 | BeOne Medicines AG | 9.76% |
| 3 | HKG: 2359 | WuXi AppTec Co., Ltd. | 8.60% |
| 4 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 8.51% |
| 5 | HKG: 9926 | Akeso, Inc. | 7.34% |
| 6 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 6.36% |
| 7 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 6.10% |
| 8 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.59% |
| 9 | n/a | Cash | 3.89% |
| 10 | HKG: 1530 | 3SBio Inc. | 3.86% |
| 11 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 3.37% |
| 12 | HKG: 2268 | WuXi XDC Cayman Inc. | 3.23% |
| 13 | HKG: 2228 | XtalPi Holdings Limited | 2.96% |
| 14 | HKG: 1548 | Genscript Biotech Corporation | 2.10% |
| 15 | HKG: 9969 | InnoCare Pharma Limited | 1.99% |
| 16 | HKG: 2162 | Keymed Biosciences Inc. | 1.89% |
| 17 | HKG: 9688 | Zai Lab Limited | 1.84% |
| 18 | HKG: 9995 | RemeGen Co., Ltd. | 1.73% |
| 19 | HKG: 0867 | China Medical System Holdings Limited | 1.68% |
| 20 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 1.15% |
| 21 | HKG: 0013 | HUTCHMED (China) Limited | 1.14% |
| 22 | HKG: 2096 | Simcere Pharmaceutical Group Limited | 1.13% |
| 23 | HKG: 6855 | Ascentage Pharma Group International | 1.11% |
| 24 | HKG: 2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 0.91% |
| 25 | HKG: 1952 | Everest Medicines Limited | 0.78% |
As of Jun 30, 2026